Publication Name	World Journal of Diabetes
Manuscript ID	4494
Country	Greece

Received	2013-07-04 09:53
Peer-Review Started	2013-07-04 10:55
First Decision by Editorial Office Director
Return for Revision	2013-09-24 14:56
Revised	2013-10-31 07:04
Publication Fee Transferred
Second Decision by Editor	2014-01-14 18:51
Second Decision by Editor-in-Chief
Final Decision by Editorial Office Director	2014-01-14 19:53
Articles in Press
Edit the Manuscript by Language Editor	2014-02-07 19:19
Typeset the Manuscript	2014-02-15 16:52
Publish the Manuscript Online	2014-02-19 15:19

ISSN	1948-9358 (online)
Open Access
Copyright
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Medicine, General & Internal
Manuscript Type	Autobiography
Article Title	Rationale, design and baseline patient characteristics of the optimal type 2 diabetes management including benchmarking and standard treatment study in Greece
Manuscript Source	Invited Manuscript
All Author List	Michael S Kostapanos, Vasilis Tsimihodimos, Moses S Elisaf, Emmanouil Tzouvelekis and Nikos Nikas
Funding Agency and Grant Number	Funding Agency Grant Number AstraZeneca
Corresponding Author	Moses S Elisaf, MD, FRSPH, FASA, Professor of Medicine, Department of Internal Medicine, School of Medicine, University of Ioannina, St. Niarchou Avenue, 45110 Ioannina, Greece. egepi@cc.uoi.gr
Key Words	Diabetes; Benchmarking; Treatment target; Glycemic control; Dyslipidemia; Blood pressure
Core Tip	This is an epidemiological study assessing the prevalence of comorbidities as well as treatment control in a Greek population of patients with type 2 diabetes.“Benchmarking” is the process of receiving feedback and comparing one’s performance to that of others. The optimal type 2 diabetes management including benchmarking and standard treatment (OPTIMISE) study is a multinational, multicenter study comparing the efficacy of two follow-up strategies in the management of type 2 diabetic outpatients: “benchmarking” vs “non-benchmarking”. This paper describes the rationale and the design of the OPTIMISE study as well as the baseline characteristics of patients included in the Greek region.
Publish Date	2014-02-19 15:19
Citation	Kostapanos MS, Tsimihodimos V, Elisaf MS, Tzouvelekis E, Nikas N. Rationale, design and baseline patient characteristics of the optimal type 2 diabetes management including benchmarking and standard treatment study in Greece. World J Diabetes 2014; 5(1): 76-83 Available from: URL: http://www. wjgnet.com/1948-9358/full/v5/i1/76.htm DOI: http://dx.doi. org/10.4239/wjd.v5.i1.76
URL	http://www.wjgnet.com/1948-9358/full/v5/i1/76.htm
DOI	http://dx.doi.org/10.4239/wjd.v5.i1.76

Full Article (PDF)	WJD-5-76.pdf
Full Article (Word)	WJD-5-76.doc
Manuscript File	4494-Review.docx
Answering Reviewers	4494-Answering reviewers.pdf
Copyright License Agreement	4494-Copyright assignment.pdf
Non-Native Speakers of English Editing Certificate	4494-Language certificate.pdf
Peer-review Report	4494-Peer reviewer(s).pdf
Scientific Editor Work List	4494-Scientific editor work list.doc